AR228859A1 - Procedimiento para la preparacion de 1-oxo-1h-tiazolo(3,2-a)pirimidin-2-(5-tetrazolil)-carboxamidas,procedimientos para preparar los compuestos intermedios utilizados en el mismo y los compuestos intermedios obtenidos con dichos procedimientos - Google Patents

Procedimiento para la preparacion de 1-oxo-1h-tiazolo(3,2-a)pirimidin-2-(5-tetrazolil)-carboxamidas,procedimientos para preparar los compuestos intermedios utilizados en el mismo y los compuestos intermedios obtenidos con dichos procedimientos

Info

Publication number
AR228859A1
AR228859A1 AR283276A AR28327680A AR228859A1 AR 228859 A1 AR228859 A1 AR 228859A1 AR 283276 A AR283276 A AR 283276A AR 28327680 A AR28327680 A AR 28327680A AR 228859 A1 AR228859 A1 AR 228859A1
Authority
AR
Argentina
Prior art keywords
intermediate compounds
tetrazolil
tiazolo
pirimidin
carboxamides
Prior art date
Application number
AR283276A
Other languages
English (en)
Spanish (es)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of AR228859A1 publication Critical patent/AR228859A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/40—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
AR283276A 1979-11-23 1980-11-18 Procedimiento para la preparacion de 1-oxo-1h-tiazolo(3,2-a)pirimidin-2-(5-tetrazolil)-carboxamidas,procedimientos para preparar los compuestos intermedios utilizados en el mismo y los compuestos intermedios obtenidos con dichos procedimientos AR228859A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9663179A 1979-11-23 1979-11-23

Publications (1)

Publication Number Publication Date
AR228859A1 true AR228859A1 (es) 1983-04-29

Family

ID=22258306

Family Applications (2)

Application Number Title Priority Date Filing Date
AR283276A AR228859A1 (es) 1979-11-23 1980-11-18 Procedimiento para la preparacion de 1-oxo-1h-tiazolo(3,2-a)pirimidin-2-(5-tetrazolil)-carboxamidas,procedimientos para preparar los compuestos intermedios utilizados en el mismo y los compuestos intermedios obtenidos con dichos procedimientos
AR290628A AR231296A1 (es) 1979-11-23 1982-09-13 Un procedimiento para la preparacion de 1-oxo-1h-tiazolo 3,2-a pirimidin-2-5-tetrazolil-carboxamida e intermediarios utilizados exclusivamente en dicho procedimiento

Family Applications After (1)

Application Number Title Priority Date Filing Date
AR290628A AR231296A1 (es) 1979-11-23 1982-09-13 Un procedimiento para la preparacion de 1-oxo-1h-tiazolo 3,2-a pirimidin-2-5-tetrazolil-carboxamida e intermediarios utilizados exclusivamente en dicho procedimiento

Country Status (35)

Country Link
JP (1) JPS5687586A (ja)
KR (1) KR830004322A (ja)
AR (2) AR228859A1 (ja)
AT (1) AT380883B (ja)
AU (1) AU520995B2 (ja)
BE (1) BE886319A (ja)
CA (1) CA1143731A (ja)
CH (1) CH649299A5 (ja)
CS (1) CS241476B2 (ja)
DD (1) DD154608A5 (ja)
DE (2) DE3043979C2 (ja)
DK (1) DK151811C (ja)
EG (1) EG14929A (ja)
ES (1) ES8203363A1 (ja)
FI (1) FI67706C (ja)
FR (1) FR2470132A1 (ja)
GB (1) GB2063862B (ja)
GR (1) GR72132B (ja)
GT (1) GT198066458A (ja)
HU (1) HU179091B (ja)
IE (1) IE50404B1 (ja)
IL (1) IL61535A (ja)
IN (1) IN154926B (ja)
IT (1) IT1209373B (ja)
LU (1) LU82950A1 (ja)
NL (1) NL182565C (ja)
NO (1) NO803521L (ja)
NZ (1) NZ195596A (ja)
PH (1) PH16666A (ja)
PL (1) PL132354B1 (ja)
PT (1) PT72090B (ja)
SE (1) SE448732B (ja)
SU (1) SU1042620A3 (ja)
YU (1) YU41953B (ja)
ZA (1) ZA807293B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8300728D0 (en) * 1983-01-12 1983-02-16 Erba Farmitalia Substituted carboxy-thiazolo / 3 2 - a / pyrimidine derivatives
US4457932A (en) * 1983-07-22 1984-07-03 Bristol-Myers Company Anti-ulcer agents
GB8422916D0 (en) * 1984-09-11 1984-10-17 May & Baker Ltd Compositions of matter
JP2690742B2 (ja) * 1987-03-30 1997-12-17 第一製薬株式会社 複素環アミン誘導体
NZ228447A (en) * 1988-03-28 1990-08-28 Janssen Pharmaceutica Nv Cosmetic or pharmaceutical composition possessing serotonin antogonistic activity
TWI500623B (zh) * 2009-10-13 2015-09-21 Torrent Pharmaceuticals Ltd 新穎稠合噻唑及噁唑嘧啶酮

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1331059A (en) * 1971-04-19 1973-09-19 Lilly Industries Ltd Pyrimidotriazinone compounds
US4041163A (en) * 1976-03-29 1977-08-09 Pfizer Inc. N-(5-Tetrazolyl)-4-oxo-4H-pyrimido(2,1-b)benzothiazole-3-carboxamide antiallergy agents
DE2810863A1 (de) * 1978-03-13 1979-09-27 Boehringer Mannheim Gmbh 1-oxo-1h-pyrimido eckige klammer auf 6,1-b eckige klammer zu benzthiazol-derivate und verfahren zu ihrer herstellung
US4223031A (en) * 1978-05-05 1980-09-16 Mead Johnson & Company Azolopyrimidinones

Also Published As

Publication number Publication date
IL61535A0 (en) 1980-12-31
LU82950A1 (fr) 1981-06-04
AR231296A1 (es) 1984-10-31
FR2470132B1 (ja) 1983-07-29
DK151811C (da) 1988-06-06
FI67706C (fi) 1985-05-10
FI803628L (fi) 1981-05-24
HU179091B (en) 1982-08-28
SE8008189L (sv) 1981-05-24
PT72090A (en) 1980-12-01
CS782080A2 (en) 1985-06-13
YU41953B (en) 1988-02-29
DE3050491C2 (de) 1985-10-10
NZ195596A (en) 1984-05-31
PL132354B1 (en) 1985-02-28
AU520995B2 (en) 1982-03-11
PT72090B (en) 1981-09-29
CS241476B2 (en) 1986-03-13
FR2470132A1 (fr) 1981-05-29
YU295080A (en) 1983-06-30
IE50404B1 (en) 1986-04-16
IT8026176A0 (it) 1980-11-21
EG14929A (en) 1989-01-30
GB2063862A (en) 1981-06-10
NL8006362A (nl) 1981-06-16
GT198066458A (es) 1982-05-15
NL182565B (nl) 1987-11-02
JPS617432B2 (ja) 1986-03-06
FI67706B (fi) 1985-01-31
DK413180A (da) 1981-05-24
SU1042620A3 (ru) 1983-09-15
CH649299A5 (fr) 1985-05-15
ES497066A0 (es) 1982-04-01
CA1143731A (en) 1983-03-29
DE3043979C2 (de) 1986-08-21
GB2063862B (en) 1983-06-22
SE448732B (sv) 1987-03-16
IT1209373B (it) 1989-07-16
PL228008A1 (ja) 1981-12-11
IN154926B (ja) 1984-12-22
JPS5687586A (en) 1981-07-16
AU6459580A (en) 1981-05-28
GR72132B (ja) 1983-09-19
ATA570780A (de) 1985-12-15
PH16666A (en) 1983-12-13
IL61535A (en) 1984-06-29
DD154608A5 (de) 1982-04-07
AT380883B (de) 1986-07-25
ES8203363A1 (es) 1982-04-01
DK151811B (da) 1988-01-04
DE3043979A1 (de) 1981-09-03
NO803521L (no) 1981-05-25
BE886319A (fr) 1981-05-25
IE802418L (en) 1981-05-23
ZA807293B (en) 1981-12-30
KR830004322A (ko) 1983-07-09
NL182565C (nl) 1988-04-05

Similar Documents

Publication Publication Date Title
ES497661A0 (es) Procedimiento para la preparacion de sulfonilureas
ES491913A0 (es) Procedimiento para la preparacion de betainas
AR224357A1 (es) Procedimiento para la preparacion de derivados de indanilo y tetrahidronaftilo y compuestos para su uso exclusivo en dicho procedimiento
AR227645A1 (es) Procedimiento para la preparacion de oxoalcohilxantinas
ES488197A0 (es) Procedimiento para la preparacion de colorantes de dioxacina
MX152233A (es) Procedimiento para la preparacion de polieterpoliaminas
ES493774A0 (es) Procedimiento para la preparacion de 3-amino-sidnoniminas
ES497100A0 (es) Procedimiento para la preparacion de sulfonilureas
AR220675A1 (es) Procedimiento para la preparacion de derivados sustituidos de pirido(1,2-a)pirimidinas
ES493300A0 (es) Procedimiento para la preparacion de acilureas
ES487746A0 (es) Procedimiento para la preparacion de bis-estiril-benceno
AR228859A1 (es) Procedimiento para la preparacion de 1-oxo-1h-tiazolo(3,2-a)pirimidin-2-(5-tetrazolil)-carboxamidas,procedimientos para preparar los compuestos intermedios utilizados en el mismo y los compuestos intermedios obtenidos con dichos procedimientos
ES494856A0 (es) Procedimiento para la preparacion de n-aril-n-acil-3-amino- oxazolidin-2-onas
ES490420A0 (es) Procedimiento para la preparacion de diestirilbifenilos
ES490421A0 (es) Procedimiento para la preparacion de diestirilbencenos
ES491527A0 (es) Procedimiento para la preparacion de tiazoliliden-oxo-pro- pionitrilos
ES488205A0 (es) Procedimiento para la preparacion de nuevas mezclas de este-res
AR225159A1 (es) Procedimiento para la preparacion de l-alpha-gliceril-fosforilcolina
MX6327E (es) Procedimiento para la preparacion de 3-alcoxi-6-alquiliden-hidrazinopiridazina
MX6151E (es) Procedimiento para la preparacion de 7-acilindolinas
ES497659A0 (es) Procedimiento para la preparacion de sulfonilureas
ES493001A0 (es) Procedimiento para la preparacion de metilglioxal
MX6162E (es) Procedimiento para la preparacion de la 2-isopropilamino-pirimidina
ES497099A0 (es) Procedimiento para la preparacion de sulfonilureas
ES493417A0 (es) Procedimiento para la preparacion de 2-isopropilamino-piri- midina